Yes, there are effective medicines for herpes. Three FDA-approved antiviral drugs treat both oral and genital herpes: acyclovir, valacyclovir, and famciclovir. These medications shorten outbreaks, reduce symptoms, and lower the chance of passing the virus to a partner. They don’t cure herpes permanently, but they give most people reliable control over the condition.
How Antiviral Medications Work
All three herpes medications belong to the same drug class and work through a remarkably targeted mechanism. When the herpes virus replicates inside your cells, it needs to copy its DNA. These antivirals disguise themselves as one of the building blocks of DNA. The virus’s own copying machinery grabs the drug and inserts it into the growing DNA chain, but the drug is missing a key piece needed to attach the next building block. The chain stops dead, and the virus can’t make new copies of itself.
What makes these drugs especially appealing is their precision. The virus’s own enzymes activate the medication, so the drug is mostly active inside infected cells. Your healthy cells have a much lower affinity for the active drug, which is why side effects tend to be mild for most people.
The Three Prescription Options
Acyclovir was the original antiviral developed for herpes and remains widely used. It’s effective but requires more frequent dosing throughout the day because the body doesn’t absorb it as efficiently.
Valacyclovir is essentially a modified version of acyclovir designed for better absorption. Once swallowed, your body converts it into acyclovir, but the improved absorption means you take it less often. For many people, this makes it the most convenient option.
Famciclovir also has high oral absorption and works through the same general mechanism. It’s a solid alternative, particularly for people who don’t tolerate the other two well. All three drugs have proven clinical benefit in randomized trials, and none is dramatically superior to the others in effectiveness. The choice often comes down to dosing convenience, cost, and insurance coverage.
Episodic vs. Daily Suppressive Therapy
There are two main strategies for using these medications, and which one fits you depends on how often outbreaks occur and how much they affect your life.
Episodic therapy means taking the medication only when you feel an outbreak starting. You begin the pills at the first sign of tingling, burning, or soreness, and continue for a short course (typically a few days). This approach shortens healing time and reduces pain but doesn’t prevent future outbreaks. It works well for people who have infrequent flare-ups.
Suppressive therapy means taking a lower dose of the medication every single day, whether or not you’re having symptoms. This strategy significantly reduces the number of outbreaks per year and also lowers the risk of transmitting the virus to a sexual partner, even during periods without visible sores. People who experience six or more outbreaks a year, or who want to minimize transmission risk in a relationship, often choose this route. Suppressive therapy has been studied over years of continuous use and is considered safe for long-term treatment in people with healthy kidney function.
Side Effects and Safety
Most people tolerate these antivirals well. Common side effects are mild: headache, nausea, and occasionally stomach discomfort. Serious reactions are uncommon in otherwise healthy individuals.
The main safety concern involves kidney function. These drugs are cleared through the kidneys, and in people with impaired kidney function, the medication can accumulate to levels that affect the nervous system. Symptoms of this buildup include confusion, agitation, hallucinations, and in rare cases seizures. These effects are generally reversible once the medication is stopped. Staying well hydrated during treatment helps protect the kidneys, and your prescriber will typically check kidney function before starting therapy and adjust the dose if needed.
Drug resistance is another concern, but it’s exceedingly rare in people with healthy immune systems. Resistance shows up more often in immunocompromised individuals, such as transplant recipients or people with HIV, who may need alternative treatments if standard antivirals stop working.
Over-the-Counter and Topical Options
A few topical products are available without a prescription, most notably docosanol (sold as Abreva) for cold sores. Prescription topical options include penciclovir cream. These products modestly decrease healing time and pain duration, but the benefit is typically less than one day compared to no treatment. They also require multiple applications per day.
The CDC explicitly discourages topical antiviral therapy for genital herpes, noting it offers minimal clinical benefit. No head-to-head trials have directly compared oral antivirals against topical treatments, but the consensus among clinicians is clear: oral medications are far more effective. If you’re dealing with genital herpes or frequent cold sores, prescription oral antivirals are the better choice.
Supplements and Alternative Remedies
L-lysine is the most studied supplement for herpes. In a six-month double-blind, multicenter trial, participants taking oral lysine supplements averaged 2.4 times fewer outbreaks than those taking a placebo. They also had less severe symptoms and shorter healing times. While this is encouraging, the evidence base is smaller and less robust than what supports prescription antivirals. Lysine is generally safe, but it shouldn’t replace antiviral medication for people with frequent or severe outbreaks.
Zinc has been explored as well, though clinical evidence for its effectiveness against herpes remains limited. Other supplements like lemon balm and propolis have preliminary data but nothing strong enough to guide treatment decisions.
New Drugs in Development
The most advanced new option is pritelivir, which works through a completely different mechanism than current antivirals. Instead of mimicking DNA building blocks, it targets a different part of the virus’s replication machinery. In a phase 3 trial involving immunocompromised patients with herpes infections that didn’t respond to standard treatment, pritelivir achieved lesion healing in 62.7% of patients compared to 34% for the best available alternative. It also caused fewer kidney-related side effects. This drug could become particularly important for the small percentage of patients whose herpes is resistant to existing antivirals.
Vaccine development has been less successful. GSK recently completed a phase I/II trial of a therapeutic herpes vaccine candidate designed to reduce outbreaks in people already infected. The vaccine did not meet its primary efficacy goal and will not advance to phase 3 studies. Several other vaccine candidates from different companies are in earlier stages of testing, but a proven herpes vaccine remains years away at best.
What Treatment Looks Like in Practice
Getting herpes medication is straightforward. A healthcare provider can prescribe it after a clinical evaluation or a positive test result. Many telehealth services now prescribe these medications remotely, making access easier than ever. Generic versions of all three antivirals are available, which keeps costs relatively low, often under $30 per month for suppressive therapy with insurance.
For a first outbreak, treatment typically lasts 7 to 10 days and can substantially reduce the severity and duration of symptoms. Recurrent episodes are shorter to begin with, and a brief course of medication (as little as one to three days, depending on the drug and dosage) can speed healing further. Many people on daily suppressive therapy find that outbreaks become rare or stop entirely, and some eventually taper off medication to see whether outbreaks return on their own, since the frequency of recurrences naturally decreases for most people over time.